The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
WINLEVI works differently from any other topical acne treatment
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Subscribe To Our Newsletter & Stay Updated
